Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circulating metabolites and fatty acids associated with ultra-processed food consumption: results from the EPIC study.

Critical reviews in food science and nutrition·2026
Same author

Development of a GMMA-based candidate vaccine against invasive nontyphoidal <i>Salmonella</i> disease.

Frontiers in immunology·2026
Same author

Human Chorionic Gonadotropin (hCG)-Induced Remodeling of the Granulosa Cell Exosomal Proteome: Implications for Follicular Communication.

Cells·2026
Same author

Understanding the impact of Klebsiella pneumoniae K-Antigen based MAPS vaccine design on the immune response in animal models.

PLoS pathogens·2026
Same author

GMMA as delivery system for Klebsiella pneumoniae O-antigens and K-antigens.

Scientific reports·2026
Same author

Immune response to rotavirus vaccines in low- and middle-income countries: Challenges and perspectives.

Human vaccines & immunotherapeutics·2026

Related Experiment Video

Updated: Jun 30, 2026

Use of Shigella flexneri to Study Autophagy-Cytoskeleton Interactions
12:52

Use of Shigella flexneri to Study Autophagy-Cytoskeleton Interactions

Published on: September 9, 2014

16.4K

Microneedle array patch delivery of Shigella flexneri 2a GMMA.

Yoona Choi1, In-Jeong Choi2, Doo Hee Shim1

  • 1Department of Microbiology and Immunology, Institute for Immunology and Immunological Diseases, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea.

Vaccine
|January 13, 2026
PubMed
Summary

A novel microneedle array patch (MAP) combined with Shigella flexneri 2a Generalized Modules for Membrane Antigens (GMMA) vaccines shows promise. This transdermal delivery method elicits robust and durable immune responses, offering a potential alternative to traditional injections for Shigella vaccine development.

Keywords:
C-MAPCoPGMMALLPCMAPOAgP-MAPSBAShigella vaccine

More Related Videos

Imaging Ca2+ Responses During Shigella Infection of Epithelial Cells
08:56

Imaging Ca2+ Responses During Shigella Infection of Epithelial Cells

Published on: May 24, 2018

5.8K
Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
04:56

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections

Published on: February 9, 2024

1.5K

Related Experiment Videos

Last Updated: Jun 30, 2026

Use of Shigella flexneri to Study Autophagy-Cytoskeleton Interactions
12:52

Use of Shigella flexneri to Study Autophagy-Cytoskeleton Interactions

Published on: September 9, 2014

16.4K
Imaging Ca2+ Responses During Shigella Infection of Epithelial Cells
08:56

Imaging Ca2+ Responses During Shigella Infection of Epithelial Cells

Published on: May 24, 2018

5.8K
Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
04:56

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections

Published on: February 9, 2024

1.5K

Area of Science:

  • Vaccinology
  • Microbiology
  • Biotechnology

Background:

  • Shigella infections cause significant global diarrheal mortality.
  • No approved vaccines are currently available for Shigella.
  • Generalized Modules for Membrane Antigens (GMMA) is an innovative vaccine platform.

Purpose of the Study:

  • To combine GMMA technology with microneedle array patches (MAPs) for Shigella vaccine delivery.
  • To evaluate the stability and immunogenicity of GMMA-loaded MAPs.
  • To compare transdermal delivery with traditional intramuscular (IM) injection.

Main Methods:

  • Two types of MAPs (coated and powder-attached) were loaded with Shigella flexneri 2a GMMA.
  • MAP quality and stability were assessed during manufacturing and storage.
  • Immunogenicity was evaluated in mice, measuring anti-OAg serum IgG and bactericidal antibodies.

Main Results:

  • Both coated-MAP (C-MAP) and powder-attached MAP (P-MAP) formats maintained quality and stability for one month.
  • Both MAP formats elicited comparable anti-OAg serum IgG and bactericidal antibodies to IM injection.
  • P-MAP demonstrated the strongest long-term immunogenicity.

Conclusions:

  • Transdermal delivery of Shigella flexneri 2a GMMA using MAPs is feasible.
  • P-MAP delivery of GMMA induces a robust and durable immune response.
  • Combining GMMA and MAP technologies presents a promising strategy for Shigella vaccine development.